I would hope that NP/CYDY would have the CD12 results completely processed and the EUA paperwork submitted to the US FDA by Valentines Day. THEN he can drop a PR.
Right after the EUA approval from the FDA comes in with share price jump, the NASDAQ uplisting paperwork gets submitted along with the EUA to Canada, Philippines, UK, and others. He can PR that after they've been submitted because they'll be less than two weeks turnaround.
Then he can PR that the HIV BLA was accepted to UK and Candada.
The NASDAQ uplisting happens and all contracts are called and closed. Share price shoots 30% on all the covers.
After that he can PR that Maboob has submitted the US HIV BLA.
While we're out shopping for our Lambos, Hatterases (??), and F650's....NP will PR that the Phase 3 for NASH has been approved.
Then he'll PR that Samsung Biologics and AGC have both cleared production of all other products to start 24/7/365 manufacturing of Leronlimab for the entire year....somewhere in gross revenue sales of $80-$100B per year for the next couple of years supplies...since it has stability for at least two years....but it probably won't be sitting on the shelf for very long since all the off label use is depleting inventories.
What we won't hear about is the secret 100,000,000 dose per year contract from the US government to stockpile for national emergency. Those revenues mysteriously show up on the balance sheet as "other income".
As we're selling 10 shares of CYDY to get first class round trip tickets to go see the Northern Lights in Sweden...we see this humble gentleman and his family...with mother-in-law in tow....that looks vaguely familiar....it's Dr. Nader Pourhassan flying with us in First Class to Stockholm to receive his Nobel Prize. What a happy flight that becomes.....
